Clinical Evidence
A Randomized Study in Diabetic Patients Undergoing Cardiac Surgery Comparing Computer-Guided Glucose Management With a Standard Sliding Scale Protocol
Objective
This prospective, randomized trial compares use of a paper protocol to a computer-guided glucose management system (EndoTool) for cardiac surgery patients receiving intravenous insulin.
Setting
1425-bed teaching hospital and Level 1 trauma center.
Results
- Percentage of blood glucoses in the desired range of 90-150 mg/dL was 81.5% higher with EndoTool during the intra-operative phase (49% vs 27%) and 40% higher during the post-operative ICU phase (84% vs 60%).
- Time in the desired range was 89% higher with EndoTool during the intra-operative phase (121 vs 64 minutes) and 42.2% higher during the post-operative ICU phase (536 vs 377 minutes).
- Time to a target blood glucose <150 mg/dL was 31.9% lower with EndoTool during the intra-operative phase (62 vs 91 minutes) and 76% lower during the post-operative ICU phase (40 vs 171 minutes).
- Overall mean average blood glucose was 30 mg/dL lower with EndoTool during the intra-operative phase (147 vs 177 mg/dL) and 21 mg/dL lower during the post-operative ICU phase (126 vs 147 mg/dL).
Conclusions
A computer-guided glucose management system (EndoTool) achieves effective and safe blood glucose control in the ICU population both during and after cardiac surgery, and more rapid and tighter glucose control than a paper protocol.
References
Authors
Leif Saager, MD; Gordon Collins, MD; Beth Burnside, BA; Heidi Tymkew, MHS; Lini Zhang, MD; Eric Jacobsohn, MBChB, MHPE, FRCPC; Michael Avidan, MBBCh, FCA.
Source
Published in Journal of Cardiothoracic and Vascular Anesthesia, Volume 22, Issue 3, p377-382.
Year
2008
Related posts
Clinical Evidence
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
Clinical Evidence
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
Clinical Evidence
EndoTool IV Leads to Over 55% Fewer Blood Glucose Checks With an 84% Decrease in Hypoglycemic Events at UPMC
EndoTool IV Leads to Over 55% Fewer Blood Glucose Checks With an 84% Decrease in Hypoglycemic Events at UPMC
Get in Touch
Ready to get started?
"*" indicates required fields